Need professional-grade analysis? Visit stockanalysis.com
$1.39B
N/A
103
N/A
Nanobiotix S.A (NANO) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at EUR28.70, up 3.02% from the previous close.
Over the past year, NANO has traded between a low of EUR2.85 and a high of EUR29.00. The stock has gained 869.6% over this period. It is currently 908.8% above its 52-week low.
Nanobiotix S.A has a market capitalization of $1.39B.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Side-by-side comparison against top Healthcare peers.